Na Jiang, Zhihong Ma, Jinjing Zhang, Lin Luo, Xingchen Huo, Jufeng Jiang, Jian Gao, Jie Huang, Dongjie Shi
{"title":"Oral Vaccination with <i>Aeromonas veronii</i> Ghost Against Lethal Bacterial Infection in <i>Cyprinus carpio</i>.","authors":"Na Jiang, Zhihong Ma, Jinjing Zhang, Lin Luo, Xingchen Huo, Jufeng Jiang, Jian Gao, Jie Huang, Dongjie Shi","doi":"10.3390/vaccines13090985","DOIUrl":null,"url":null,"abstract":"<p><strong>Background/objectives: </strong><i>Aeromonas veronii</i> is a significant pathogen affecting aquatic animals and has the potential to infect humans. Vaccination remains the most effective strategy for preventing infections caused by this bacterial strain.</p><p><strong>Methods: </strong>This study aimed to validate the efficacy of bacterial ghosts as an oral vaccine by administering them to <i>Cyprinus carpio</i> and evaluating the resultant innate and acquired immune responses. Following immunization, the vaccinated <i>Cyprinus carpio</i> were exposed to a lethal dose of the wild-type bacterial strain to assess survival rates and relative protection efficiency.</p><p><strong>Results: </strong>Oral vaccination with bacterial ghosts led to the significant enhancement of lysozyme (LZM) and myeloperoxidase (MPO) activity in koi serum. It also resulted in the upregulation of cytokines, such as IL-2 and TNF-α, as well as an increase in both systemic (IgM) and mucosal (IgZs) antibody responses. The immunized group demonstrated reduced cumulative mortality following bacterial challenge. The relative percent survival in the vaccinated group reached as high as 87.50%.</p><p><strong>Conclusions: </strong>The oral immunization of <i>Cyprinus carpio</i> with <i>A. veronii</i>-derived bacterial ghosts confers substantial immune protection, providing a foundational basis for the development of novel vaccines against <i>A. veronii</i>.</p>","PeriodicalId":23634,"journal":{"name":"Vaccines","volume":"13 9","pages":""},"PeriodicalIF":5.2000,"publicationDate":"2025-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12474343/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vaccines","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/vaccines13090985","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background/objectives: Aeromonas veronii is a significant pathogen affecting aquatic animals and has the potential to infect humans. Vaccination remains the most effective strategy for preventing infections caused by this bacterial strain.
Methods: This study aimed to validate the efficacy of bacterial ghosts as an oral vaccine by administering them to Cyprinus carpio and evaluating the resultant innate and acquired immune responses. Following immunization, the vaccinated Cyprinus carpio were exposed to a lethal dose of the wild-type bacterial strain to assess survival rates and relative protection efficiency.
Results: Oral vaccination with bacterial ghosts led to the significant enhancement of lysozyme (LZM) and myeloperoxidase (MPO) activity in koi serum. It also resulted in the upregulation of cytokines, such as IL-2 and TNF-α, as well as an increase in both systemic (IgM) and mucosal (IgZs) antibody responses. The immunized group demonstrated reduced cumulative mortality following bacterial challenge. The relative percent survival in the vaccinated group reached as high as 87.50%.
Conclusions: The oral immunization of Cyprinus carpio with A. veronii-derived bacterial ghosts confers substantial immune protection, providing a foundational basis for the development of novel vaccines against A. veronii.
VaccinesPharmacology, Toxicology and Pharmaceutics-Pharmacology
CiteScore
8.90
自引率
16.70%
发文量
1853
审稿时长
18.06 days
期刊介绍:
Vaccines (ISSN 2076-393X) is an international, peer-reviewed open access journal focused on laboratory and clinical vaccine research, utilization and immunization. Vaccines publishes high quality reviews, regular research papers, communications and case reports.